Loading...
BVMFRADL3
Market cap6.48bUSD
Dec 20, Last price  
22.98BRL
1D
1.28%
1Q
-14.79%
Jan 2017
-61.77%
IPO
64.50%
Name

Raia Drogasil SA

Chart & Performance

D1W1MN
BVMF:RADL3 chart
P/E
37.36
P/S
1.16
EPS
0.62
Div Yield, %
1.18%
Shrs. gr., 5y
-0.22%
Rev. gr., 5y
18.08%
Revenues
33.97b
+16.88%
426,918,000539,166,000674,425,000833,069,0001,260,147,0001,720,548,0002,005,216,0002,729,392,0005,380,728,0006,232,919,0007,391,569,0008,897,849,00011,256,565,00013,212,505,00014,801,445,00017,565,600,00020,066,840,00024,127,002,00029,067,380,00033,973,790,000
Net income
1.05b
+5.91%
7,951,0009,725,00020,795,00021,626,00051,173,00074,590,00089,015,00068,696,000104,855,000100,985,000221,386,000340,206,000447,685,000511,163,000502,447,000772,240,000484,444,000751,934,000996,112,0001,054,973,000
CFO
1.79b
+6.13%
11,066,00016,667,00016,859,00028,718,000-24,463,00074,232,00052,446,00028,619,000105,334,000305,743,000359,926,000501,695,000555,529,000628,840,000682,866,000965,211,0001,477,238,0001,550,545,0001,682,255,0001,785,327,000
Dividend
Oct 04, 20240.12833 BRL/sh
Earnings
Mar 03, 2025

Profile

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. As of March 31, 2022, the company operated a network of 2,530 drug stores in 26 Brazilian states. It also markets its goods through telesales and its three call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.
URL
https://www.rd.com.br
IPO date
Oct 20, 2010
Employees
55,219
Domiciled in
BR
Incorporated in
BR

Valuation

Title
BRL in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
33,973,790
16.88%
29,067,380
20.48%
24,127,002
20.23%
Cost of revenue
31,959,227
27,313,751
22,799,987
Unusual Expense (Income)
NOPBT
2,014,563
1,753,629
1,327,015
NOPBT Margin
5.93%
6.03%
5.50%
Operating Taxes
129,550
178,241
223,129
Tax Rate
6.43%
10.16%
16.81%
NOPAT
1,885,013
1,575,388
1,103,886
Net income
1,054,973
5.91%
996,112
32.47%
751,934
55.22%
Dividends
(465,901)
(324,082)
(265,025)
Dividend yield
0.93%
0.83%
0.63%
Proceeds from repurchase of equity
191,798
BB yield
-0.46%
Debt
Debt current
1,463,068
186,356
613,831
Long-term debt
9,541,157
8,852,263
7,538,017
Deferred revenue
Other long-term liabilities
382,218
302,942
295,392
Net debt
10,576,951
8,600,599
7,794,900
Cash flow
Cash from operating activities
1,785,327
1,682,255
1,550,545
CAPEX
(1,304,581)
(1,188,782)
(855,596)
Cash from investing activities
(1,307,123)
(1,229,582)
(885,950)
Cash from financing activities
(499,424)
(375,250)
(1,188,834)
FCF
(103,919)
447,847
584,354
Balance
Cash
412,321
433,541
356,118
Long term investments
14,953
4,479
830
Excess cash
Stockholders' equity
5,961,509
5,349,419
4,675,231
Invested Capital
13,173,305
11,004,494
9,493,144
ROIC
15.59%
15.37%
11.59%
ROCE
15.29%
15.94%
13.98%
EV
Common stock shares outstanding
1,695,194
1,719,821
1,719,936
Price
29.40
28.89%
22.81
-6.13%
24.30
-2.96%
Market cap
49,838,704
27.05%
39,229,118
-6.14%
41,794,457
-2.93%
EV
60,487,955
47,891,796
49,630,486
EBITDA
3,675,909
3,269,167
2,654,125
EV/EBITDA
16.46
14.65
18.70
Interest
737,787
292,690
228,230
Interest/NOPBT
36.62%
16.69%
17.20%